334 related articles for article (PubMed ID: 32117746)
1.
Kluiver TA; Alieva M; van Vuurden DG; Wehrens EJ; Rios AC
Front Oncol; 2020; 10():92. PubMed ID: 32117746
[TBL] [Abstract][Full Text] [Related]
2. Design considerations of an IL13Rα2 antibody-drug conjugate for diffuse intrinsic pontine glioma.
Lian X; Kats D; Rasmussen S; Martin LR; Karki A; Keller C; Berlow NE
Acta Neuropathol Commun; 2021 May; 9(1):88. PubMed ID: 34001278
[TBL] [Abstract][Full Text] [Related]
3. Development of a human in vitro blood-brain tumor barrier model of diffuse intrinsic pontine glioma to better understand the chemoresistance.
Deligne C; Hachani J; Duban-Deweer S; Meignan S; Leblond P; Carcaboso AM; Sano Y; Shimizu F; Kanda T; Gosselet F; Dehouck MP; Mysiorek C
Fluids Barriers CNS; 2020 Jun; 17(1):37. PubMed ID: 32487241
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
[TBL] [Abstract][Full Text] [Related]
5. Diffuse intrinsic pontine glioma: molecular landscape and emerging therapeutic targets.
Aziz-Bose R; Monje M
Curr Opin Oncol; 2019 Nov; 31(6):522-530. PubMed ID: 31464759
[TBL] [Abstract][Full Text] [Related]
6. Proceedings of the diffuse intrinsic pontine glioma (DIPG) Toronto Think Tank: advancing basic and translational research and cooperation in DIPG.
Bartels U; Hawkins C; Vézina G; Kun L; Souweidane M; Bouffet E
J Neurooncol; 2011 Oct; 105(1):119-25. PubMed ID: 21901544
[TBL] [Abstract][Full Text] [Related]
7. Genomic Insights into Diffuse Intrinsic Pontine Glioma.
Lapin DH; Tsoli M; Ziegler DS
Front Oncol; 2017; 7():57. PubMed ID: 28401062
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Targeted Therapy for Diffuse Intrinsic Pontine Glioma.
Hashizume R
Neurol Med Chir (Tokyo); 2017 Jul; 57(7):331-342. PubMed ID: 28592748
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy.
Lieberman NAP; DeGolier K; Kovar HM; Davis A; Hoglund V; Stevens J; Winter C; Deutsch G; Furlan SN; Vitanza NA; Leary SES; Crane CA
Neuro Oncol; 2019 Jan; 21(1):83-94. PubMed ID: 30169876
[TBL] [Abstract][Full Text] [Related]
10. Diffuse Intrinsic Pontine Glioma: Molecular Landscape, Evolving Treatment Strategies and Emerging Clinical Trials.
Damodharan S; Lara-Velazquez M; Williamsen BC; Helgager J; Dey M
J Pers Med; 2022 May; 12(5):. PubMed ID: 35629262
[TBL] [Abstract][Full Text] [Related]
11. A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands.
Veldhuijzen van Zanten SE; Jansen MH; Sanchez Aliaga E; van Vuurden DG; Vandertop WP; Kaspers GJ
Expert Rev Anticancer Ther; 2015 Feb; 15(2):157-64. PubMed ID: 25435089
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of tumor growth and post-irradiation recurrence in a diffuse intrinsic pontine glioma mouse model.
Caretti V; Zondervan I; Meijer DH; Idema S; Vos W; Hamans B; Bugiani M; Hulleman E; Wesseling P; Vandertop WP; Noske DP; Kaspers G; Molthoff CF; Wurdinger T
Brain Pathol; 2011 Jul; 21(4):441-51. PubMed ID: 21159008
[TBL] [Abstract][Full Text] [Related]
13. HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine glioma.
Wang SS; Davenport AJ; Iliopoulos M; Hughes-Parry HE; Watson KA; Arcucci V; Mulazzani M; Eisenstat DD; Hansford JR; Cross RS; Jenkins MR
Neurooncol Adv; 2023; 5(1):vdad024. PubMed ID: 37152812
[TBL] [Abstract][Full Text] [Related]
14. Tumor dissemination through surgical tracts in diffuse intrinsic pontine glioma.
Lobon-Iglesias MJ; Santa-Maria Lopez V; Puerta Roldan P; Candela-Cantó S; Ramos-Albiac M; Gomez-Chiari M; Puget S; Bolle S; Goumnerova L; Kieran MW; Cruz O; Grill J; Morales La Madrid A
J Neurosurg Pediatr; 2018 Dec; 22(6):678-683. PubMed ID: 30192215
[TBL] [Abstract][Full Text] [Related]
15. Receptor-driven invasion profiles in diffuse intrinsic pontine glioma.
Karki A; Berlow NE; Kim JA; Hulleman E; Liu Q; Michalek JE; Keller C
Neurooncol Adv; 2021; 3(1):vdab039. PubMed ID: 34013206
[TBL] [Abstract][Full Text] [Related]
16. Pediatric diffuse intrinsic pontine glioma: where do we stand?
Rashed WM; Maher E; Adel M; Saber O; Zaghloul MS
Cancer Metastasis Rev; 2019 Dec; 38(4):759-770. PubMed ID: 31802357
[TBL] [Abstract][Full Text] [Related]
17. Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry.
Gits HC; Anderson M; Stallard S; Pratt D; Zon B; Howell C; Kumar-Sinha C; Vats P; Kasaian K; Polan D; Matuszak M; Spratt DE; Leonard M; Qin T; Zhao L; Leach J; Chaney B; Escorza NY; Hendershot J; Jones B; Fuller C; Leary S; Bartels U; Bouffet E; Yock TI; Robertson P; Mody R; Venneti S; Chinnaiyan AM; Fouladi M; Gottardo NG; Koschmann C
Acta Neuropathol Commun; 2018 Jul; 6(1):67. PubMed ID: 30049282
[TBL] [Abstract][Full Text] [Related]
18. Identification of new therapeutic targets and natural compounds against diffuse intrinsic pontine glioma (DIPG).
Chen J; Lin Z; Barrett L; Dai L; Qin Z
Bioorg Chem; 2020 Jun; 99():103847. PubMed ID: 32311581
[TBL] [Abstract][Full Text] [Related]
19. Diffuse Intrinsic Pontine Glioma (DIPG): Breakthrough and Clinical Perspective.
Perrone MG; Ruggiero A; Centonze A; Carrieri A; Ferorelli S; Scilimati A
Curr Med Chem; 2021; 28(17):3287-3317. PubMed ID: 32767913
[TBL] [Abstract][Full Text] [Related]
20. Polo-like Kinase 1 as a potential therapeutic target in Diffuse Intrinsic Pontine Glioma.
Amani V; Prince EW; Alimova I; Balakrishnan I; Birks D; Donson AM; Harris P; Levy JM; Handler M; Foreman NK; Venkataraman S; Vibhakar R
BMC Cancer; 2016 Aug; 16():647. PubMed ID: 27538997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]